Home
>
National Drug Code (NDC)
>
Arava
Arava - 0088-2162-33 - (leflunomide)
Drug Information of Arava
| Product NDC: | 0088-2162 |
| Proprietary Name: | Arava |
| Non Proprietary Name: | leflunomide |
| Active Ingredient(s): | 100 mg/1 & nbsp; leflunomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Arava
| Product NDC: | 0088-2162 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020905 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980919 |
Package Information of Arava
| Package NDC: | 0088-2162-33 |
| Package Description: | 3 TABLET, FILM COATED in 1 BLISTER PACK (0088-2162-33) |
NDC Information of Arava
| NDC Code | 0088-2162-33 |
| Proprietary Name | Arava |
| Package Description | 3 TABLET, FILM COATED in 1 BLISTER PACK (0088-2162-33) |
| Product NDC | 0088-2162 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | leflunomide |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980919 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | LEFLUNOMIDE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antirheumatic Agent [EPC] |
